Strengthen Brazil’s National Response to HIV and other diseases through innovative and evidence-based approaches in laboratory, strategic information, prevention and care activities and foster partnerships between Brazil, Angola and Mozambique unde | CDC RFA GH13 134305CONT17

Opportunity Information: Apply for CDC RFA GH13 134305CONT17

This grant opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under PEPFAR (the President's Emergency Plan for AIDS Relief). Its central purpose is to strengthen Brazil's national response to HIV and other diseases by supporting practical, evidence-based improvements across the full public health cycle: laboratory systems, strategic information (data and surveillance), prevention services, and care and treatment activities. In addition to strengthening work inside Brazil, the opportunity explicitly emphasizes fostering partnerships and collaboration among Brazil, Angola, and Mozambique, reflecting a broader goal of shared learning and capacity-building across Portuguese-speaking countries with connected public health priorities.

The focus on laboratories signals support for activities that improve the quality, reliability, and reach of diagnostic and monitoring services, which are essential for HIV programs and for broader disease control. In practical terms, that often includes strengthening testing networks, improving quality management systems, ensuring consistent use of standards, and helping laboratories generate results that can be trusted for clinical decision-making and for national reporting. Strong lab capacity directly supports faster diagnosis, better patient monitoring, and more accurate program performance measurement, which are core needs in HIV response and in the control of other infectious diseases.

The strategic information component points to investments in data systems and analytic capacity so that Brazil's HIV response is guided by timely, accurate evidence rather than assumptions. This typically includes surveillance, routine program monitoring, data quality improvement, and using information to target interventions to the populations and locations where they are most needed. Strategic information also covers the ability to translate data into decisions, meaning improvements in reporting pipelines, dashboards, evaluation activities, and the workforce skills needed to interpret and act on findings. In an HIV context, this kind of work supports understanding epidemic trends, identifying gaps in testing and treatment, and tracking outcomes such as linkage to care and viral suppression.

On prevention and care, the opportunity is framed to support approaches that are innovative but still grounded in evidence, suggesting a balance between proven interventions and the adaptation of new models to local realities. Prevention activities can include strengthening outreach and service delivery strategies, improving integration with other health services, and ensuring that prevention efforts are aligned with epidemiologic data. Care and treatment strengthening generally centers on improving the quality and continuity of services, supporting systems that retain people in care, and reinforcing clinical and program practices that lead to better health outcomes. Because the announcement references "HIV and other diseases," it implies that improvements should be designed in ways that also strengthen broader public health infrastructure and can be leveraged across disease areas, not just HIV alone.

A distinguishing feature of this opportunity is the explicit intent to foster partnerships between Brazil, Angola, and Mozambique. That emphasis suggests support for cross-country collaboration, including the exchange of technical expertise, sharing best practices, and developing joint approaches that can be adapted across national health systems. This can take the form of coordinated training, mentorship relationships, harmonized laboratory and surveillance approaches where appropriate, and structured knowledge-sharing mechanisms. The partnership framing also aligns with the concept of building sustainable, locally rooted capacity that persists beyond a single project period, by strengthening institutions and professional networks rather than only funding isolated activities.

From an administrative standpoint, the opportunity is identified as CDC RFA GH13-134305CONT17 and is categorized as continuation funding, meaning it is intended to continue or extend previously supported work rather than launch a brand-new, open competition. The funding instrument is a cooperative agreement, which generally indicates substantial involvement by CDC in programmatic collaboration, technical guidance, and monitoring, rather than a hands-off grant model. The CFDA number listed is 93.067, placing it within CDC's global health assistance portfolio. The posting lists an expected number of awards of 10. The award ceiling is shown as 0 in the source data, which typically means the ceiling was not specified in the summary record or was to be determined based on available funds and negotiated workplans rather than capped at a fixed published maximum.

Eligibility is listed broadly as "Others," with a note to consult the additional eligibility text in the full announcement for clarification, implying that eligibility may be limited to specific organizations, existing partners, or entities meeting particular criteria tied to the continuation nature of the funding. The notice was created on February 1, 2017, with an original closing date of March 3, 2017, indicating a relatively short application window that is common for continuation or amendment-related opportunities where applicants are often already engaged in the program area and prepared to submit updates or continuation proposals.

Overall, this opportunity is aimed at reinforcing Brazil's capacity to run a high-performing, data-driven HIV response supported by strong laboratory systems and integrated prevention and care services, while also building durable technical bridges with Angola and Mozambique. The structure as a CDC cooperative agreement under PEPFAR points to an emphasis on measurable public health impact, close technical coordination, and strengthening systems that can sustain progress against HIV and contribute to wider disease control objectives.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthen Brazil’s National Response to HIV and other diseases through innovative and evidence-based approaches in laboratory, strategic information, prevention and care activities and foster partnerships between Brazil, Angola and Mozambique unde" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 01, 2017.
• Applicants must submit their applications by Mar 03, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH13 134305CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: